FHX
3-[(3S,4R)-3-methyl-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,7-diazaspiro[3.4]octan-1-yl]-3-oxidanylidene-propanenitrile
Find entries where: FHX
is present as a standalone ligand in 1 entries
Chemical Component Summary | |
---|---|
Name | 3-[(3S,4R)-3-methyl-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,7-diazaspiro[3.4]octan-1-yl]-3-oxidanylidene-propanenitrile |
Identifiers | 3-[(3~{S},4~{R})-3-methyl-7-(7~{H}-pyrrolo[2,3-d]pyrimidin-4-yl)-1,7-diazaspiro[3.4]octan-1-yl]-3-oxidanylidene-propanenitrile |
Formula | C16 H18 N6 O |
Molecular Weight | 310.354 |
Type | NON-POLYMER |
Isomeric SMILES | C[C@H]1CN([C@]12CCN(C2)c3c4cc[nH]c4ncn3)C(=O)CC#N |
InChI | InChI=1S/C16H18N6O/c1-11-8-22(13(23)2-5-17)16(11)4-7-21(9-16)15-12-3-6-18-14(12)19-10-20-15/h3,6,10-11H,2,4,7-9H2,1H3,(H,18,19,20)/t11-,16-/m0/s1 |
InChIKey | LOWWYYZBZNSPDT-ZBEGNZNMSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 41 |
Chiral Atom Count | 2 |
Bond Count | 44 |
Aromatic Bond Count | 10 |
Drug Info: DrugBank
DrugBank ID | DB16133 |
---|---|
Name | Delgocitinib |
Groups | investigational |
Description | Delgocitinib is under investigation in clinical trial NCT03683719 (Phase 2b Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 Mg/g Compared to Delgocitinib Cream Vehicle Over a 16-week Treatment Period in Adult Subjects With Chronic Hand Eczema). |
Synonyms | Delgocitinib |
CAS number | 1263774-59-9 |
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL4297507 |
PubChem | 50914062 |
ChEMBL | CHEMBL4297507 |